the aid library

Slowing of the HIV Epidemic in Ukraine: Evidence from Case Reporting and Key Population Surveys, 2005–2012

C. R. Vitek; J.-I. Cakalo; Y .V. Kruglov; et al. PLOS One (2014) C2

PLOS ONE | www.plosone.org September 2014 | Volume 9 | Issue 9 | e103657

‘Virus Carriers’ and HIV testing: navigating Ukraine’s HIV policies and programming for female sex workers

A. Tokar; J. Osborne; K. Slobodianiuk; et al. BMC Public Health (BioMed Central); Health Research Policy and Systems (2019) CC

Tokar et al. Health Research Policy and Systems (2019) 17:23 https://doi.org/10.1186/s12961-019-0415-4

Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV - Policy Brief

World Health Organization (2018) C_WHO

HIV Treatment - Interim Guidance

HIV Molecular diagnostics Toolkit to improve access to viral load testing and infant diagnosis

WHO World Health Organization (2019) C_WHO

Toolkit HIV Treatment and Care

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection - AIDSinfo

AIDSinfo (2019) C2

Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019 Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office of AIDS Research Advisory Council (OARAC)

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

D. Ford; R. Turner; A. Turkova; et al. JAIDS Journal of Acquired Immune Deficiency Syndromes; Ovid (2018) C2

Supplement Article www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018

The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis

P. J. Dodd; A. J. Prendergas; C. Beecroft; et al. BMJ Journals (2017) CC

BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421

Tuberculosis and HIV—An Update on the “Cursed Duet” in Children

S. H.-L. Fry; S. L. Barnabas; Mark F. Cotton; E. André Frontiers in Pediatrics (2019) C2

Frontiers in Pediatrics | www.frontiersin.org 1 April 2019 | Volume 7 | Article 159

Caregiving and Experiences of Health, Illness and Coping in the Context of Paediatric and Adolescent HIV and Poverty

A. G. Lentoor Web of Science; INTECH (2018) C2

We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists Selection of our books indexed in the Book Citation Index in Web of ScienceTM Core Collection (BKCI) http://dx.doi.org/10.5772/intechopen.68759

Management of mental health disorders in HIV-positive patients

G. Jonsson; N. Davies; C. Freeman; et al. Southern African HIV Clinicians Society; AOSIS Publishing (2013) C2

Guideline SAJHIVMED DECEMBER 2013, Vol. 14, No. 4

Novel point-of-care tools for early infant diagnosis of HIV

World Health Organization (2017) C_WHO

HIV Diagnostics Information Note WHO/HIV/2017.16

Mother-to-child transmission of HIV infection and its associated factors in Ethiopia: a systematic review and meta-analysis

G. M. Kassa BMC Infectious Diseases; PubMed.gov (2018) CC

Kassa BMC Infectious Diseases (2018) 18:216 https://doi.org/10.1186/s12879-018-3126-5

Guidelines for the vaccination of HIV-infected adolescents and adults in South Africa

S. K. Dlamini; S. A. Madhi; R. Muloiwa; et al. Southern African Journal of HIV Medicine; AOSIS (2018) CC

Southern African Journal of HIV Medicine ISSN: (Online) 2078-6751, (Print) 1608-9693 http://www.sajhivmed.org.za Published: 23 May 2018

Barriers and facilitators to antiretroviral therapy adherence among Peruvian adolescents living with HIV: A qualitative study

J. T. Galea; M. Wong; M. Muñoz; et al. PLOS ONE; PMC (2018) CC

Research Article PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018

WHO/HIVRESNET HIV drug resistance - laboratory operational framework

World Health Organization WHO (2020) C_WHO

The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ... more

HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis

World Health Organization WHO (2020) C_WHO

WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches. HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i ... more